Mycophenolate Mofetil in severe or methotrexate refractory localized scleroderma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1546-0096
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Mycophenolate Mofetil in severe or methotrexate refractory localized scleroderma ; volume:6 ; number:1 ; day:15 ; month:9 ; year:2008 ; pages:1 ; date:9.2008
Pediatric rheumatology ; 6, Heft 1 (15.9.2008), 1, 9.2008
- Urheber
-
Martini, G.
Falcini, F.
Girschick, H.
Goldsmidt, D.
Zulian, F.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1546-0096-6-S1-P229
- URN
-
urn:nbn:de:101:1-2019090115394642588860
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Martini, G.
- Falcini, F.
- Girschick, H.
- Goldsmidt, D.
- Zulian, F.
- SpringerLink (Online service)
Ähnliche Objekte (12)
A Scoping Review of the Efficacy and Safety of Methotrexate Compared to Mycophenolate Mofetil in the Treatment of Juvenile Localized Scleroderma in Children and Young Adults
Cyclophosphamide versus mycophenolate mofetil in scleroderma interstitial lung disease (SSc-ILD) as induction therapy: a single-centre, retrospective analysis
Mycophenolate mofetil use in refractory juvenile systemic lupus erythematosus
Autoimmune Ascites Responding to Mycophenolate Mofetil: A Case Report
Extracranial linear localized scleroderma associated with longstanding epileptic encephalopathy unresponding to methotrexate and prednisone
Is Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life?
Risk of failing both methotrexate and mycophenolate mofetil from the First-line Antimetabolites as Steroid-sparing Treatment (FAST) uveitis trial
Sites of gastrointestinal lesion induced by mycophenolate mofetil: a comparison with enteric-coated mycophenolate sodium in rats
Mycophenolate mofetil in patients with refractory systemic autoimmune myopathies: case series
The effect of mycophenolate mofetil on podocytes in nephrotoxic serum nephritis
A placebo-controlled pilot study of intensification of antiretroviral therapy with mycophenolate mofetil
Mycophenolate mofetil inhibits the development of Coxsackie B3-virus-induced myocarditis in mice
A Scoping Review of the Efficacy and Safety of Methotrexate Compared to Mycophenolate Mofetil in the Treatment of Juvenile Localized Scleroderma in Children and Young Adults
Cyclophosphamide versus mycophenolate mofetil in scleroderma interstitial lung disease (SSc-ILD) as induction therapy: a single-centre, retrospective analysis
Mycophenolate mofetil use in refractory juvenile systemic lupus erythematosus
Autoimmune Ascites Responding to Mycophenolate Mofetil: A Case Report
Extracranial linear localized scleroderma associated with longstanding epileptic encephalopathy unresponding to methotrexate and prednisone
Is Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life?
Risk of failing both methotrexate and mycophenolate mofetil from the First-line Antimetabolites as Steroid-sparing Treatment (FAST) uveitis trial
Sites of gastrointestinal lesion induced by mycophenolate mofetil: a comparison with enteric-coated mycophenolate sodium in rats
Mycophenolate mofetil in patients with refractory systemic autoimmune myopathies: case series
The effect of mycophenolate mofetil on podocytes in nephrotoxic serum nephritis
A placebo-controlled pilot study of intensification of antiretroviral therapy with mycophenolate mofetil
Mycophenolate mofetil inhibits the development of Coxsackie B3-virus-induced myocarditis in mice
A Scoping Review of the Efficacy and Safety of Methotrexate Compared to Mycophenolate Mofetil in the Treatment of Juvenile Localized Scleroderma in Children and Young Adults
Cyclophosphamide versus mycophenolate mofetil in scleroderma interstitial lung disease (SSc-ILD) as induction therapy: a single-centre, retrospective analysis
Mycophenolate mofetil use in refractory juvenile systemic lupus erythematosus
Autoimmune Ascites Responding to Mycophenolate Mofetil: A Case Report
Extracranial linear localized scleroderma associated with longstanding epileptic encephalopathy unresponding to methotrexate and prednisone
Is Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life?
Risk of failing both methotrexate and mycophenolate mofetil from the First-line Antimetabolites as Steroid-sparing Treatment (FAST) uveitis trial
Sites of gastrointestinal lesion induced by mycophenolate mofetil: a comparison with enteric-coated mycophenolate sodium in rats
Mycophenolate mofetil in patients with refractory systemic autoimmune myopathies: case series
The effect of mycophenolate mofetil on podocytes in nephrotoxic serum nephritis
A placebo-controlled pilot study of intensification of antiretroviral therapy with mycophenolate mofetil